Presentation is loading. Please wait.

Presentation is loading. Please wait.

Characteristics of lymphocyte subsets in HIV-infected, long-term nonprogressor, and healthy Asian children through 12 years of age  Jintanat Ananworanich,

Published byGudrun Lindholm Modified over 6 years ago

Similar presentations

Presentation on theme: "Characteristics of lymphocyte subsets in HIV-infected, long-term nonprogressor, and healthy Asian children through 12 years of age  Jintanat Ananworanich,"— Presentation transcript:

1 Characteristics of lymphocyte subsets in HIV-infected, long-term nonprogressor, and healthy Asian children through 12 years of age  Jintanat Ananworanich, MD, PhD, Tanakorn Apornpong, MSc, Pope Kosalaraksa, MD, Tanyathip Jaimulwong, BSc, Rawiwan Hansudewechakul, MD, Chitsanu Pancharoen, MD, Torsak Bunupuradah, MD, Mom Chandara, MSc, Thanyawee Puthanakit, MD, Chaiwat Ngampiyasakul, MD, Jurai Wongsawat, MD, Suparat Kanjanavanit, MD, Wicharn Luesomboon, MD, Phennapha Klangsinsirikul, PhD, Nicole Ngo-Giang-Huong, PharmD, PhD, Stephen J. Kerr, PhD, Sasiwimol Ubolyam, MSc, Tawan Mengthaisong, RN, Rebecca S. Gelman, PhD, Kovit Pattanapanyasat, PhD, Vonthanak Saphonn, MD, PhD, Kiat Ruxrungtham, MD, MSc, William T. Shearer, MD, PhD  Journal of Allergy and Clinical Immunology  Volume 126, Issue 6, Pages e10 (December 2010) DOI: /j.jaci Copyright © 2010 American Academy of Allergy, Asthma & Immunology Terms and Conditions

2 Fig 1 Comparison of cell subsets among 4 age groups of HIV-positive and healthy children. A, CD45+/CD3+/CD19− (total T cells). B, CD45+/CD3+/CD4+ (TH cells). C, CD45+/CD3+/CD8+ (cytotoxic T cells). D, CD45+/CD3−/CD19+ (B cells). E, CD45+/CD3−/CD16+/CD56+ (NK cells). ∗P < .05. No. of children: <2 to 3 years (n = 79), 4 to 5 years (n = 74), 6 to 8 years (n = 135), 9 to 12 years (n = 76). Pos, Positive. Journal of Allergy and Clinical Immunology  , e10DOI: ( /j.jaci ) Copyright © 2010 American Academy of Allergy, Asthma & Immunology Terms and Conditions

3 Fig 1 Comparison of cell subsets among 4 age groups of HIV-positive and healthy children. A, CD45+/CD3+/CD19− (total T cells). B, CD45+/CD3+/CD4+ (TH cells). C, CD45+/CD3+/CD8+ (cytotoxic T cells). D, CD45+/CD3−/CD19+ (B cells). E, CD45+/CD3−/CD16+/CD56+ (NK cells). ∗P < .05. No. of children: <2 to 3 years (n = 79), 4 to 5 years (n = 74), 6 to 8 years (n = 135), 9 to 12 years (n = 76). Pos, Positive. Journal of Allergy and Clinical Immunology  , e10DOI: ( /j.jaci ) Copyright © 2010 American Academy of Allergy, Asthma & Immunology Terms and Conditions

4 Fig 1 Comparison of cell subsets among 4 age groups of HIV-positive and healthy children. A, CD45+/CD3+/CD19− (total T cells). B, CD45+/CD3+/CD4+ (TH cells). C, CD45+/CD3+/CD8+ (cytotoxic T cells). D, CD45+/CD3−/CD19+ (B cells). E, CD45+/CD3−/CD16+/CD56+ (NK cells). ∗P < .05. No. of children: <2 to 3 years (n = 79), 4 to 5 years (n = 74), 6 to 8 years (n = 135), 9 to 12 years (n = 76). Pos, Positive. Journal of Allergy and Clinical Immunology  , e10DOI: ( /j.jaci ) Copyright © 2010 American Academy of Allergy, Asthma & Immunology Terms and Conditions

5 Comparison of cell subsets between HIV-positive and healthy children for 4 age groups. CD4+/45RA+/62L+ (naive TH cells). ∗P < .05. No. of children: <2 to 3 years (n = 79), 4 to 5 years (n = 74), 6 to 8 years (n = 135), 9 to 12 years (n = 76). Pos, Positive. Journal of Allergy and Clinical Immunology  , e10DOI: ( /j.jaci ) Copyright © 2010 American Academy of Allergy, Asthma & Immunology Terms and Conditions

6 Comparison of cell subsets between HIV-positive and healthy children for 4 age groups. CD3+/4+/45RO+ (memory TH cells). ∗P < .05. No. of children: <2 to 3 years (n = 79), 4 to 5 years (n = 74), 6 to 8 years (n = 135), 9 to 12 years (n = 76). Pos, Positive. Journal of Allergy and Clinical Immunology  , e10DOI: ( /j.jaci ) Copyright © 2010 American Academy of Allergy, Asthma & Immunology Terms and Conditions

7 Comparison of cell subsets between HIV-positive and healthy children for 4 age groups. CD4+/DR+/38+ (activated TH cells). ∗P < .05. No. of children: <2 to 3 years (n = 79), 4 to 5 years (n = 74), 6 to 8 years (n = 135), 9 to 12 years (n = 76). Pos, Positive. Journal of Allergy and Clinical Immunology  , e10DOI: ( /j.jaci ) Copyright © 2010 American Academy of Allergy, Asthma & Immunology Terms and Conditions

8 Comparison of cell subsets between HIV-positive and healthy children for 4 age groups. CD8+/45RA+/62L+ (naive cytotoxic T cells). ∗P < .05. No. of children: <2 to 3 years (n = 79), 4 to 5 years (n = 74), 6 to 8 years (n = 135), 9 to 12 years (n = 76). Pos, Positive. Journal of Allergy and Clinical Immunology  , e10DOI: ( /j.jaci ) Copyright © 2010 American Academy of Allergy, Asthma & Immunology Terms and Conditions

9 Comparison of cell subsets between HIV-positive and healthy children for 4 age groups. CD3+/4-/45RO+ (memory cytotoxic T cells). ∗P < .05. No. of children: <2 to 3 years (n = 79), 4 to 5 years (n = 74), 6 to 8 years (n = 135), 9 to 12 years (n = 76). Pos, Positive. Journal of Allergy and Clinical Immunology  , e10DOI: ( /j.jaci ) Copyright © 2010 American Academy of Allergy, Asthma & Immunology Terms and Conditions

10 Comparison of cell subsets between HIV-positive and healthy children for 4 age groups. CD8+/DR+/38+ (activated cytotoxic T cells). ∗P < .05. No. of children: <2 to 3 years (n = 79), 4 to 5 years (n = 74), 6 to 8 years (n = 135), 9 to 12 years (n = 76). Pos, Positive. Journal of Allergy and Clinical Immunology  , e10DOI: ( /j.jaci ) Copyright © 2010 American Academy of Allergy, Asthma & Immunology Terms and Conditions

Download ppt "Characteristics of lymphocyte subsets in HIV-infected, long-term nonprogressor, and healthy Asian children through 12 years of age  Jintanat Ananworanich,"

Similar presentations

Joint modeling of parentally reported and physician-confirmed wheeze identifies children with persistent troublesome wheezing Danielle C.M. Belgrave, MSc,

Joint modeling of parentally reported and physician-confirmed wheeze identifies children with persistent troublesome wheezing Danielle C.M. Belgrave, MSc,
A bioinformatics approach to identify patients with symptomatic peanut allergy using peptide microarray immunoassay Jing Lin, PhD, Francesca M. Bruni,

A bioinformatics approach to identify patients with symptomatic peanut allergy using peptide microarray immunoassay Jing Lin, PhD, Francesca M. Bruni,
Early exposure to cow's milk protein is protective against IgE-mediated cow's milk protein allergy Yitzhak Katz, MD, Nelly Rajuan, MSc, Michael R. Goldberg,

Early exposure to cow's milk protein is protective against IgE-mediated cow's milk protein allergy Yitzhak Katz, MD, Nelly Rajuan, MSc, Michael R. Goldberg,
Control of immunopathology during chikungunya virus infection Caroline Petitdemange, PhD, Nadia Wauquier, PhD, Vincent Vieillard, PhD Journal of Allergy.

Control of immunopathology during chikungunya virus infection Caroline Petitdemange, PhD, Nadia Wauquier, PhD, Vincent Vieillard, PhD Journal of Allergy.
Defective B-cell memory in patients with Down syndrome Ruud H.J. Verstegen, MD, Gertjan J. Driessen, MD, Sophinus J.W. Bartol, BSc, Carel J.M. van Noesel,

Defective B-cell memory in patients with Down syndrome Ruud H.J. Verstegen, MD, Gertjan J. Driessen, MD, Sophinus J.W. Bartol, BSc, Carel J.M. van Noesel,
Characteristics of childhood peanut allergy in the Australian Capital Territory, 1995 to 2007 Raymond James Mullins, MBBS, PhD, FRACP, FRCPA, Keith B.G.

Characteristics of childhood peanut allergy in the Australian Capital Territory, 1995 to 2007 Raymond James Mullins, MBBS, PhD, FRACP, FRCPA, Keith B.G.
Endoplasmic reticulum stress influences bronchial asthma pathogenesis by modulating nuclear factor κB activation So Ri Kim, MD, PhD, Dong Im Kim, MS, Mi.

Endoplasmic reticulum stress influences bronchial asthma pathogenesis by modulating nuclear factor κB activation So Ri Kim, MD, PhD, Dong Im Kim, MS, Mi.
What drives prescription patterns in pediatric asthma management?

What drives prescription patterns in pediatric asthma management?
Joseph A. Odhiambo, MMed, Hywel C. Williams, PhD, Tadd O

Joseph A. Odhiambo, MMed, Hywel C. Williams, PhD, Tadd O
Association of CD4+ T-lymphocyte counts and new thymic emigrants in HIV-infected children during successful highly active antiretroviral therapy  Akihiko.

Association of CD4+ T-lymphocyte counts and new thymic emigrants in HIV-infected children during successful highly active antiretroviral therapy  Akihiko.
Increased incidence of asthma in HIV-infected children treated with highly active antiretroviral therapy in the National Institutes of Health Women and.

Increased incidence of asthma in HIV-infected children treated with highly active antiretroviral therapy in the National Institutes of Health Women and.
Obstructive sleep apnea syndrome and inflammation

Obstructive sleep apnea syndrome and inflammation
Santa Jeremy Ono, BA, PhD, Mark B. Abelson, MD 

Santa Jeremy Ono, BA, PhD, Mark B. Abelson, MD 
Immunologic defects in 22q11.2 deletion syndrome

Immunologic defects in 22q11.2 deletion syndrome
Reference values for peripheral blood lymphocyte subsets of healthy children in China  Yuan Ding, MD, Lina Zhou, MS, Yu Xia, MD, Wei Wang, MS, Ying Wang,

Reference values for peripheral blood lymphocyte subsets of healthy children in China  Yuan Ding, MD, Lina Zhou, MS, Yu Xia, MD, Wei Wang, MS, Ying Wang,
Long-term immune reconstitution after matched unrelated hematopoietic stem cell transplantation for immunodeficiency  Vy Hong-Diep Kim, MD, Brenda Reid,

Long-term immune reconstitution after matched unrelated hematopoietic stem cell transplantation for immunodeficiency  Vy Hong-Diep Kim, MD, Brenda Reid,
Is 9 more than 2 also in allergic airway inflammation?

Is 9 more than 2 also in allergic airway inflammation?
Probiotics during the first 7 years of life: A cumulative risk reduction of eczema in a randomized, placebo-controlled trial  Marko Kalliomäki, MD, PhD,

Probiotics during the first 7 years of life: A cumulative risk reduction of eczema in a randomized, placebo-controlled trial  Marko Kalliomäki, MD, PhD,
Desensitization to Chemotherapeutic Agents

Desensitization to Chemotherapeutic Agents
Hospitalization rates and prognosis of patients with anaphylactic shock in Denmark from 1995 through 2012  Anni Nørgaard Jeppesen, MD, Christian Fynbo.

Hospitalization rates and prognosis of patients with anaphylactic shock in Denmark from 1995 through 2012  Anni Nørgaard Jeppesen, MD, Christian Fynbo.

Similar presentations

Ads by Google